Hims & Hers Health, Inc. — Form 8-K Summary
Business context and reporting period
Filed March 18, 2021, under Item 2.02 to report operating results for the quarter and full year ended December 31, 2020. The company also issued financial guidance for the first quarter and full year 2021. The filing identifies Hims & Hers Health as an emerging growth company, with Class A common stock and warrants listed on the NYSE.
Financial results and liquidity
The filing itself does not provide revenue, profit or loss, cash flow, margin, debt, liquidity, subscriber, or other operating metrics. Those results were included in Exhibit 99.1, the March 18, 2021 press release, but the press release text is not included in the provided filing content.
Changes versus the prior comparable period
The filing announces results for the fourth quarter and full year 2020, but it does not state the amounts or year-over-year changes. The filing text does not provide a clear basis for quantifying changes versus the prior comparable periods.
Guidance, outlook, risks, and unusual items
Management issued guidance for the first quarter and full year 2021. The guidance amounts and assumptions are not included in the provided text. No specific risks, contingencies, unusual items, or management commentary are described in the filing body.
Investor verification items
- Obtain and review Exhibit 99.1 for 2020 revenue, profitability, cash flow, margins, balance-sheet metrics, and operating statistics.
- Verify the reported fourth-quarter and full-year 2020 results against the prior comparable periods.
- Verify first-quarter and full-year 2021 guidance, including revenue, adjusted EBITDA or other profitability targets, and key assumptions.
- Review the company’s subsequent periodic filings for audited financial statements, liquidity, debt, and risk disclosures.